Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (11-20 of 687) with videos related to

Pageof 69
Sort By:
Journal of the American College of Cardiology|July 13, 2005
Would you give a beta-blocker and/or aldosterone antagonist to a patient with an ejection fraction (EF) of 30 who has never had symptoms of heart failure?Bertram Pitt
Heart Failure Reviews|October 15, 2011
The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failureBertram Pitt
European Journal of Heart Failure|November 20, 2012
Adverse events in HEAAL: when to hold and when to foldBertram Pitt
Polskie Archiwum Medycyny Wewnetrznej|March 25, 2010
Angiotensin receptor blockers in patients with heart failure and a reduced left ventricular ejection fraction. Implications of the HEAAL trialBertram Pitt
American Heart Journal|November 8, 2002
New insights into the role of aldosterone in cardiorenal disease and the clinical implications. IntroductionBertram Pitt
Annals of Internal Medicine|April 21, 2010
Review: remote patient monitoring of patients with heart failure reduces mortality and heart failure admissionsBertram Pitt
Journal of Clinical Hypertension (Greenwich, Conn.)|September 16, 2009
The role of chlorthalidone in patients with high-risk hypertensionBertram Pitt
Current Heart Failure Reports|June 3, 2009
Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?Bertram Pitt
Journal of Cardiac Failure|January 30, 2003
Do diuretics and aldosterone receptor antagonists improve ventricular remodeling?Bertram Pitt
ACP Journal Club|September 5, 2003
Higher serum digoxin levels were associated with increased mortality in CHFBertram Pitt
Pageof 69

Showing results (11-20 of 687) with videos related to

Sort By:
Pageof 69
Journal of the American College of Cardiology|July 13, 2005
Would you give a beta-blocker and/or aldosterone antagonist to a patient with an ejection fraction (EF) of 30 who has never had symptoms of heart failure?Bertram Pitt
Heart Failure Reviews|October 15, 2011
The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failureBertram Pitt
European Journal of Heart Failure|November 20, 2012
Adverse events in HEAAL: when to hold and when to foldBertram Pitt
Polskie Archiwum Medycyny Wewnetrznej|March 25, 2010
Angiotensin receptor blockers in patients with heart failure and a reduced left ventricular ejection fraction. Implications of the HEAAL trialBertram Pitt
American Heart Journal|November 8, 2002
New insights into the role of aldosterone in cardiorenal disease and the clinical implications. IntroductionBertram Pitt
Annals of Internal Medicine|April 21, 2010
Review: remote patient monitoring of patients with heart failure reduces mortality and heart failure admissionsBertram Pitt
Journal of Clinical Hypertension (Greenwich, Conn.)|September 16, 2009
The role of chlorthalidone in patients with high-risk hypertensionBertram Pitt
Current Heart Failure Reports|June 3, 2009
Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?Bertram Pitt
Journal of Cardiac Failure|January 30, 2003
Do diuretics and aldosterone receptor antagonists improve ventricular remodeling?Bertram Pitt
ACP Journal Club|September 5, 2003
Higher serum digoxin levels were associated with increased mortality in CHFBertram Pitt
Pageof 69